[Use of benzodiazepines in prolonged seizures and status epilepticus in the community].
Anales de pediatria (Barcelona, Spain · 2014-11-04 · Other / unclear
Abstract
Prolonged seizures and status epilepticus are common neurological medical emergencies. Early and appropriate treatment is essential to reduce morbidity and mortality. Most seizures occur in the community, so parents and caregivers must be prepared for their management. Benzodiazepines (BZD) are the first-line drugs used, with rectal diazepam (DZPr) being the most commonly used in pre-hospital treatment in Spain. In September 2011, the European Medicines Agency (EMA) authorized the use of oromucosal midazolam (MDZb) for the treatment of prolonged acute convulsive seizures in patients aged 3 months to <18 years. MDZb has a rapid onset, short duration of effect, and avoids first-pass hepatic metabolism. MDZb has shown to be at least as or more effective than DZPr to stop the seizures. Buccal administration is easier and more socially accepted, especially in adolescents and adults. It is a safe drug with similar effects to other BZD; MDZb improves the overall cost-effectiveness of seizures management.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Sedatives & anxiolytics · Midazolam · Children · Diazepam · Other benzodiazepines & Z-drugs
Related articles
- Efficacy and safety of intranasal and buccal midazolam versus intravenous, intramuscular, and rectal benzodiazepines for the termination of acute seizures in children: a systematic review and meta-analysis. (Seizure, 2026)
- Termination of seizures in the paediatric age group, best benzodiazepine and route of administration: A network meta-analysis. (Eur J Neurosci, 2022)
- Prehospital Seizure Management in Children: An Evaluation of a Nationally Representative Sample. (J Pediatr, 2023)
- Efficacy, safety, route of administration of midazolam and diazepam for pediatric status epilepticus: systematic review, meta-analysis, and trial sequential analysis. (Pediatr Res, 2026)
- Recommendations for the community-based management of prolonged convulsive seizures in children in Europe. (BMC Pediatr, 2026)
- Japanese guidelines for treatment of pediatric status epilepticus - 2023. (Brain Dev, 2025)